The epidermal growth factor receptor as a target for therapy in breast carcinoma
Authors:
- 1 January 1994
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 29 (1) , 127-138
Abstract
The epidermal growth factor (EGF) receptor and its ligands have an important regulatory role in breast carcinoma. We have produced a series of monoclonal antibodies (MAbs) directed against the external portion of the EGF receptor. These MAbs prevent the binding of the ligands to the receptor, block ligand-induced activation of the receptor, and can inhibit the growth of breast cancer cells both in tissue culture and in human tumor xenografts in nude mice. We have also shown that anti-EGF receptor antibodies greatly enhance the antitumor effects of chemotherapeutic agents active in breast cancer. Phase I clinical trials with single doses of MAb conducted in patients with tumors over-expressing EGF receptors demonstrated favorable pharmacokinetics, good tumor imaging, and a lack of toxicity. A human:murine chimeric antibody has been produced with comparable affinity and antitumor activity that will enable us to administer repeated doses of MAb either alone or in combination with chemotherapy. Our pre-clinical data support the concept that the EGF receptor may be an optimal target for treatment with receptor blocking antibodies, either alone or in combination with chemotherapy.Keywords
This publication has 59 references indexed in Scilit:
- Interference of the IGF system as a strategy to inhibit breast cancer growthBreast Cancer Research and Treatment, 1992
- Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibodyJournal of Cellular Physiology, 1990
- Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosisNature, 1990
- Imaging of Human Tumor Xenografts With an Indium-111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal AntibodyJNCI: Journal of the National Cancer Institute, 1989
- mRNA Expression of Transforming Growth Factor Alpha in Human Breast Carcinomas and Its Activity in Effusions of Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 1989
- RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENSAnnual Review of Biochemistry, 1987
- Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agentsEuropean Journal of Cancer and Clinical Oncology, 1987
- Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.Journal of Clinical Pathology, 1985
- Epidermal growth factor receptors in human breast cancerBreast Cancer Research and Treatment, 1984
- Adriamycin causes up regulation of epidermal growth factor receptors in actively growing cellsExperimental Cell Research, 1983